A disease in which the myelin sheaths – the insulating covers of the body’s nerve fibers – are damaged, multiple sclerosis is believed to affect more than 2 million people worldwide. Most commonly diagnosed between the ages of 20 and 40, the course of the illness can take several forms. In relapsing-remitting forms of the disease symptoms tend to appear, disappear, and then return again; in progressive forms they build up over time.
Symptoms are wide-ranging and vary between patients but can include visual disturbances; muscle weakness; coordination and balance problems; sensations such as numbness, prickling pains or ‘pins and needles’; and memory problems. In some people the disease results in sufferers losing the ability to write, speak, or walk.
Significantly, therefore, there is mounting evidence that a lack of vitamin D may increase the risk of developing multiple sclerosis. Analyzing data on over 14 thousand people suffering from the disease and around 24 thousand without it, a study published in 2015 found that those with a genetic tendency to vitamin D deficiency were twice as likely to develop the neurological disorder. With vitamin D insufficiency now known to be widespread and supplementation being both safe and cost-effective, the researchers stated that their findings may have important public health implications.
To read a case report on the successful control of multiple sclerosis using Dr. Rath’s Cellular Medicine approach, see this article on our website.
Taking Higher-Than-Recommended Doses Of Vitamin D For Five Years Reduces Risk Of Atrial Fibrillation
July 14, 2023Nearly Half Of Tap Water Americans Drink Is Tainted With ‘Forever Chemicals’
July 14, 2023Vitamin D May Reduce Fatigue Associated With Multiple Sclerosis
News
A new systematic review and meta-analysis of available randomized controlled trials has concluded that vitamin D supplementation may reduce fatigue associated with multiple sclerosis.
[Source: nutraingredients.com]
Comment
A disease in which the myelin sheaths – the insulating covers of the body’s nerve fibers – are damaged, multiple sclerosis is believed to affect more than 2 million people worldwide. Most commonly diagnosed between the ages of 20 and 40, the course of the illness can take several forms. In relapsing-remitting forms of the disease symptoms tend to appear, disappear, and then return again; in progressive forms they build up over time.
Symptoms are wide-ranging and vary between patients but can include visual disturbances; muscle weakness; coordination and balance problems; sensations such as numbness, prickling pains or ‘pins and needles’; and memory problems. In some people the disease results in sufferers losing the ability to write, speak, or walk.
Significantly, therefore, there is mounting evidence that a lack of vitamin D may increase the risk of developing multiple sclerosis. Analyzing data on over 14 thousand people suffering from the disease and around 24 thousand without it, a study published in 2015 found that those with a genetic tendency to vitamin D deficiency were twice as likely to develop the neurological disorder. With vitamin D insufficiency now known to be widespread and supplementation being both safe and cost-effective, the researchers stated that their findings may have important public health implications.
To read a case report on the successful control of multiple sclerosis using Dr. Rath’s Cellular Medicine approach, see this article on our website.
Dr. Rath Health Foundation
Related posts
Germany Identifies its First Case of New Mpox Variant
Read more